Back to Search
MARK GITTLEMAN, M.D.
M.D.
Surgery Physician
NPI: 1215912274Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
MD012169E(PA)
Research & Publications (19)
Single-step ultrasound localization of breast lesions and lumpectomy procedure.
PMID 14553856·Am J Surg·2003
8-other
Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial.
PMID 19319606·Ann Surg Oncol·2009
8-other
Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial.
PMID 19268900·Am J Surg·2009
4-observational
Timing of Chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial.
PMID 18692330·Int J Radiat Oncol Biol Phys·2008
4-observational
Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer.
PMID 18646045·Cancer·2008
3-trial
Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
PMID 18181095·Cancer·2008
3-trial
Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast.
PMID 16788759·Ann Surg Oncol·2006
3-trial
Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial.
PMID 16164915·Am J Surg·2005
3-trial
First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
PMID 16088962·Cancer·2005
3-trial
Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia.
PMID 15072886·Urology·2004
3-trial
A prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a new lesion localization device.
PMID 12383892·Am J Surg·2002
3-trial
A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer.
PMID 11912385·J Urol·2002
3-trial
2001 Image-guided percutaneous breast cancer ablation meeting at the American Society of Breast Surgeons.
PMID 11720686·Am J Surg·2001
8-other
The Therapeutic Realizations Scale-Revised (TRS-R): psychometric characteristics and relationship to treatment process and outcome.
PMID 10987692·J Clin Psychol·2000
8-other
Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra).
PMID 10736486·Urology·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2775 SCHOENERSVILLE RD
BETHLEHEM, PA 18017 - Phone
- (610) 861-8080
Quick Facts
- NPI
- 1215912274
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile